BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Leiting JL, Grotz TE. Optimizing outcomes for patients with gastric cancer peritoneal carcinomatosis. World J Gastrointest Oncol 2018; 10(10): 282-289 [PMID: 30364780 DOI: 10.4251/wjgo.v10.i10.282]
URL: https://www.wjgnet.com/1948-5204/full/v10/i10/282.htm
Number Citing Articles
1
Guangcai Niu, Xiangdong Ma. Peritoneal cancer index is a prognostic indicator of survival in advanced gastric cancer with peritoneal carcinomatosisOncology and Translational Medicine 2020; 6(3): 116 doi: 10.1007/s10330-019-0381-1
2
Lili Ai, Hao Wang. Effects of propofol and sevoflurane on tumor killing activity of peripheral blood natural killer cells in patients with gastric cancerJournal of International Medical Research 2020; 48(3) doi: 10.1177/0300060520904861
3
Jieun Yun, Sang-Bae Han, Hong Jun Kim, Se-il Go, Won Sup Lee, Woo Kyun Bae, Sang-Hee Cho, Eun-Kee Song, Ok-Jun Lee, Hee Kyung Kim, Yaewon Yang, Jihyun Kwon, Hee Bok Chae, Ki Hyeong Lee, Hye Sook Han. Exosomal miR-181b-5p Downregulation in Ascites Serves as a Potential Diagnostic Biomarker for Gastric Cancer-associated Malignant AscitesJournal of Gastric Cancer 2019; 19(3): 301 doi: 10.5230/jgc.2019.19.e27
4
Veena Sangwan, Luai Al-Marzouki, Sanjima Pal, Vivian Stavrakos, Malak Alzahrani, Dorothy Antonatos, Yehonatan Nevo, Sophie Camilleri-Broët, Roni Rayes, France Bourdeau, Betty Giannias, Nicholas Bertos, Swneke Bailey, Simon Rousseau, Jonathan Cools-Lartigue, Jonathan D. Spicer, Lorenzo Ferri. Inhibition of LPS-mediated TLR4 activation abrogates gastric adenocarcinoma-associated peritoneal metastasisClinical & Experimental Metastasis 2022; 39(2): 323 doi: 10.1007/s10585-021-10133-8
5
Antonio Macrì, Federico Morabito. The use of intraperitoneal chemotherapy for gastric malignanciesExpert Review of Anticancer Therapy 2019; 19(10): 879 doi: 10.1080/14737140.2019.1671189
6
Megan Fallows, Ambareesh Samant, Harry Wilson, Reza Mirnezami. A Systematic Review of Surgical Management Strategies in the Treatment of Peritoneal Carcinomatosis of Neuroendocrine OriginCurrent Oncology 2023; 30(7): 6316 doi: 10.3390/curroncol30070466
7
Si Ying Adelina Ho, Kon Voi Tay. Systematic review of diagnostic tools for peritoneal metastasis in gastric cancer-staging laparoscopy and its alternativesWorld Journal of Gastrointestinal Surgery 2023; 15(10): 2280-2293 doi: 10.4240/wjgs.v15.i10.2280
8
Giorgio Maria Masci, Fabio Ciccarelli, Fabrizio Ivo Mattei, Damiano Grasso, Fabio Accarpio, Carlo Catalano, Andrea Laghi, Paolo Sammartino, Franco Iafrate. Role of CT texture analysis for predicting peritoneal metastases in patients with gastric cancerLa radiologia medica 2022; 127(3): 251 doi: 10.1007/s11547-021-01443-8
9
K. R. Ishmuratova, K. Sh. Gantsev. New views on pathogenesis and diagnosis of peritoneal carcinomatosisCreative surgery and oncology 2023; 12(4): 328 doi: 10.24060/2076-3093-2022-12-4-328-336
10
Xin Hu, Liuxing Wu, Ben Liu, Kexin Chen. Immune Infiltration Subtypes Characterization and Identification of Prognosis-Related lncRNAs in Adenocarcinoma of the Esophagogastric JunctionFrontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.651056
11
Marek Mazurek, Małgorzata Szlendak, Alicja Forma, Jacek Baj, Ryszard Maciejewski, Giandomenico Roviello, Luigi Marano, Franco Roviello, Karol Polom, Robert Sitarz. Hyperthermic Intraperitoneal Chemotherapy in the Management of Gastric Cancer: A Narrative ReviewInternational Journal of Environmental Research and Public Health 2022; 19(2): 681 doi: 10.3390/ijerph19020681
12
Ravi J. Chokshi, Jin K. Kim, Jimmy Patel, Joseph B. Oliver, Omar Mahmoud. Impact of insurance status on overall survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)Pleura and Peritoneum 2020; 5(3) doi: 10.1515/pp-2020-0105